Logo
Lumi 10.0 (1x3ml)

Lumi 10.0 (1x3ml)

Dermaren

Skin Boosters
  • Marketed by multiple European and UK aesthetic suppliers as a sterile injectable cosmetic/mesotherapy product combining polynucleotides and hyaluronic acid.
  • Manufactured by Across Co. Ltd., a South Korean company that produces Dermaren Branded aesthetic injectables for international distribution.
  • Distributors commonly state that Dermaren Lumi 10.0 is supplied through European channels and that their product ranges are CE Marked where required, although specific CE certificate details and classification for this product are not consistently published.
Polynucleotide & hyaluronic acid tissue stimulator

Description

Lumi 10.0 (Dermaren Lumi 10.0) is a biorevitalising skin booster and tissue stimulator that combines polynucleotides (PDRN) of salmon origin with semi-bound hyaluronic acid to regenerate damaged skin, deliver deep hydration and smooth fine lines and wrinkles. Supplied as a 1 x 3 ml pre-filled syringe, it is designed for professional mesotherapy-style treatments of the face, neck and décolletage, stimulating collagen and elastin synthesis, improving skin texture and radiance, and providing long-lasting rejuvenation.

Bnefits

  • Provides intense, long-lasting hydration and plumping of the skin, helping to smooth fine lines and superficial wrinkles.
  • Stimulates collagen and elastin production via polynucleotides (PDRN), supporting regeneration of damaged tissues and improved skin elasticity.
  • Improves overall skin quality, texture and radiance, giving a more youthful, luminous appearance.
  • Supports recovery after traumatic or aggressive aesthetic procedures by aiding tissue repair and hydration.
  • Helps brighten and even skin tone, addressing dullness and certain superficial pigmentation concerns.
  • Delivers a synergistic effect from the combination of hyaluronic acid and polynucleotides for volumisation and bio-revitalisation.
  • Formulated for use on the face, neck and décolletage, with additional off-face applications (such as hands) described by some distributors.

Indications

  • Bio-revitalisation and regeneration of photoaged or environmentally damaged skin.
  • Fine lines and superficial wrinkles on the face, neck and décolletage.
  • Loss of elasticity, firmness and skin density.
  • Dry, dehydrated or dull-looking skin requiring deep moisturisation.
  • Supportive treatment after traumatic aesthetic procedures (e.g., laser, peels or microneedling) when clinically appropriate.
  • Volumisation and improvement of skin texture in selected areas as per professional assessment.

Composition

  • Hyaluronic acid (HA) 10 mg/ml in a 3 ml pre-filled syringe (semi-bound / semi-conjugated HA).
  • Polynucleotide (PDRN) 10 mg/ml of animal origin (purified salmon fish milk DNA).
  • Some marketing materials additionally reference glutathione as an antioxidant component.
  • Sterile injectable solution for intradermal / mesotherapy-style administration by trained professionals only.

Formulation

  • Biorevitalising tissue stimulator based on a combination of polynucleotides (PDRN) and semi-bound hyaluronic acid.
  • High-viscosity formulation designed to provide a long-lasting, modulating effect on skin cells and extracellular matrix.
  • Intended for mesotherapy-style intradermal or superficial subdermal injection into treatment areas such as face, neck and décolletage.
  • Packaged as a sterile, ready-to-use 3 ml pre-filled syringe for single-patient use.

Packaging

  • 1 x 3 ml pre-filled syringe of Lumi 10.0 per box.
  • Box commonly includes a 27G x 13 mm needle supplied by some distributors.
  • Sterile, single-use presentation for professional in-clinic treatments.
  • Available to clinics and practitioners in multipacks (e.g., 1, 5, 10 or 20 boxes) via aesthetic wholesalers.

Usage

  • For professional use only; treatment must be performed by appropriately trained and qualified healthcare or aesthetic practitioners in accordance with local regulations.
  • Conduct a full medical consultation and skin assessment, including evaluation of indications, expectations, and contraindications before treatment.
  • Cleanse and disinfect the treatment area thoroughly; remove makeup, skincare products and any self-tan from the skin.
  • Using an appropriate technique (e.g., micro-bolus, nappage, or other mesotherapy-style method), inject small amounts of product into the dermis or superficial subdermis of the face, neck and/or décolletage, following the manufacturer’s and distributor’s guidance and local clinical protocols.
  • Typical treatment plans described by distributors suggest that a full facial treatment uses the full 3 ml syringe, with sessions repeated at roughly 30-day intervals, but exact protocol should be set by the treating practitioner.
  • After injection, gently massage the area if appropriate to distribute the product evenly and minimise lumpiness, following best practice and patient comfort.
  • Provide post-treatment care advice, including avoidance of makeup for several hours, avoidance of saunas and intense exercise for 24–48 hours, and rigorous sun protection.
  • Do not reuse any opened syringe; any remaining product after a single treatment should be discarded safely as medical waste.
  • Always refer to the official instructions for use and any local clinical guidelines for detailed administration recommendations.

Contraindications

  • Known hypersensitivity or allergy to any component of the product, including hyaluronic acid or polynucleotides of salmon origin.
  • Active skin infections, inflammatory skin conditions, or open wounds at or near the intended injection sites.
  • Autoimmune diseases or immunosuppression where injectable aesthetic procedures are contraindicated, unless cleared by a specialist.
  • History of severe allergies, anaphylaxis or serious adverse reactions to injectable aesthetic treatments, unless carefully evaluated and monitored by an appropriate specialist.
  • Pregnancy and breastfeeding, as aesthetic injectable treatments are generally avoided due to limited safety data.
  • Known coagulation disorders, current anticoagulant therapy or uncontrolled systemic disease where the risk of bleeding or complications is increased, unless managed in close consultation with the patient’s physician.
  • Recent aggressive dermatologic procedures (e.g., deep chemical peels, ablative lasers) in the proposed treatment area until adequate healing has occurred.
  • Any other contraindications outlined in the manufacturer’s instructions for use or local clinical guidelines.

Adverse Effects

  • Common, usually transient injection-site reactions such as redness, swelling, tenderness, bruising, itching or mild pain.
  • Temporary lumps, papules or unevenness at injection sites, typically resolving as the product integrates into the tissue.
  • Less common events such as inflammatory reactions, prolonged oedema or nodules, which may require clinical assessment and management.
  • Rare but serious risks shared with other injectable products, including infection, abscess, vascular compromise or necrosis if inadvertent intravascular injection occurs; urgent management according to local protocols is required in such situations.
  • Allergic or hypersensitivity reactions to any component of the product; in very rare cases, immediate medical intervention may be necessary.

Storage Conditions

  • Store at a controlled temperature between 2 °C and 25 °C, as specified by distributors.
  • Do not freeze; freezing may damage the product and alter its performance.
  • Keep the product in its original packaging to protect it from light and contamination until use.
  • Store in a secure, clean medical environment out of the reach of unauthorised persons and children.
  • Do not use after the expiry date indicated on the packaging or if the sterile blister or syringe appears damaged or compromised.

Duration

Distributors and clinic protocols commonly describe a course of several sessions (for example, 2\u20133 or more treatments spaced approximately 3\u20134 weeks apart), with results often reported as lasting around 6\u201312 months depending on individual skin condition, lifestyle and treatment plan. Maintenance or top-up sessions may be scheduled according to clinical judgement and patient response.

Onset

Patients typically notice an increase in hydration and improved skin radiance shortly after treatment, with progressive improvement in texture, firmness and fine lines developing over several weeks as collagen and tissue regeneration are stimulated.

Browse more Skin Boosters

Top Treatments

Top Cities in the UK